Symantec Ventures has exited mobile cybersecurity platform developer Appthority in an acquisition of undisclosed size by its parent company.

American Family Ventures and GV have exited property rental platform developer Cozy in a $68m acquisition by CoStar that followed about $18m in funding.

University of Southampton spinout Exosect has been put up for sale by Hilco Streambank in an effort to salvage the pest and disease control technology producer.

Merck & Co, Accenture and UPS are all set to exit application integration and data management platform developer Liaison Technologies through the acquisition.

Orchard Therapeutics has listed in the US following a $200m initial public offering that came just three years after the gene therapy developer was spun out of UCL.

A round up of all the latest news on www.globalcorporateventuring.com for our subscribers

Illumina, WuXi PharmaTech, Kangmei and Institut Mérieux-backed synthetic DNA producer Twist Bioscience floated at the bottom of its range.

UCL Technology Fund-backed gene therapy developer Orchard Therapeutics raised $200m in an offering that could possibly close at $230m.

GSK, Sphera Global and Medison-backed gene therapy developer Orchard Therapeutics raised $200m in an offering that could possibly close at $230m.

Stanford-StartX Fund has exited business intelligence software provider DataFox in an acquisition of undisclosed size by Oracle.